AstraZeneca chief executive Pascal Soriot is considering moving the company's stock exchange listing from the UK to the US – ...

The 7th Exosome-Based Therapeutics Development Summit with never-before-seen data, covering the end-to-end from discovery ...

The One Big Beautiful Bill (BBB), which passed (PDF) by a 51-50 vote with Vice President JD Vance casting the tie-breaker, ...

Touchstone and Rowley highlight why companies like Eli Lilly, Novo Nordisk, and Genentech are choosing to set up shop in ...

The next frontier in clinical development is modelling feasibility and continuous scenario-planning, even amid changing ...

At this year’s Veeva R&D and Quality Summit, it was revealed that Novo Nordisk and Veeva have entered into a new partnership ...

The 7th Exosome-Based Therapeutics Development Summit with never-before-seen data, covering the end-to-end from discovery ...

The analysis by the Royal College of Paediatrics and Child Health suggests the main barriers to access are factors like ...

For the first time ever, the Inaugural Multi-Omics Based Drug Discovery & Development Summit 2025 has been positioned as the ...

A new task force comprising staff from the UK medicines regulator, the MHRA, and cost-effectiveness arbiter NICE – with the ...

Cosmo Feilding Mellen – currently Beckley's chief executive, who is slated to serve as chief strategy officer of the merged ...

ASCO 2025 spotlighted new data across haematologic cancers this year. To discuss announcements in liquid cancers further, as ...